Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062298
Company: PHARMOBEDIENT
Company: PHARMOBEDIENT
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ERY-TAB | ERYTHROMYCIN | 250MG | TABLET, DELAYED RELEASE;ORAL | Prescription | AB | No | No |
| ERY-TAB | ERYTHROMYCIN | 500MG | TABLET, DELAYED RELEASE;ORAL | Prescription | AB | No | Yes |
| ERY-TAB | ERYTHROMYCIN | 333MG | TABLET, DELAYED RELEASE;ORAL | Prescription | AB | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 12/04/2013 | SUPPL-68 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf |